-
After Flap Reconstruction, Complications More Likely in Women With Higher BMI
After Flap Reconstruction, Complications More Likely in Women With Higher BMI Apr 10, 2024 Women with a higher body mass index have a higher risk of complications after flap breast reconstruction. Read more…
-
Breaking Research News from Breastcancer.org
Breastcancer.org strives to bring you updates on the latest breast cancer research through its Research News program. Medical experts at Breastcancer.org provide easy-to-understand summaries of what the research means for YOU. Favorite this thread to get notifications on all the breaking news about current breast cancer…
-
Risk of Death Lasts for 20 Years in Men With Early-Stage, Hormone Receptor-Positive Breast Cancer
Risk of Death Lasts for 20 Years in Men With Early-Stage, Hormone Receptor-Positive Breast Cancer Apr 10, 2024 Men with early-stage, hormone receptor-positive breast cancer have a fairly high risk of dying from breast cancer, even 20 years after diagnosis. Read more…
-
In Triple-Negative Breast Cancer, Response to Chemotherapy Before Surgery Varies by Race and Ethnici
In Triple-Negative Breast Cancer, Response to Chemotherapy Before Surgery Varies by Race and Ethnicity Apr 8, 2024 After chemotherapy before surgery for triple-negative breast cancer, Black women are less likely and Hispanic women are more likely than white women to have a pathologic complete response. Read more…
-
ASCO and SSO Update Genetic Testing Guidelines for People With Breast Cancer
ASCO and SSO Update Genetic Testing Guidelines for People With Breast Cancer Apr 8, 2024 Updated guidelines say anyone age 65 or younger diagnosed with breast cancer should have genetic testing for BRCA1 and BRCA2 mutations. Read more…
-
Ovary Removal, MRI Screening for Breast Cancer Saves Lives in Women With BRCA Mutation
Ovary Removal, MRI Screening for Breast Cancer Saves Lives in Women With BRCA Mutation Mar 18, 2024 Women with a BRCA1 or BRCA2 mutation have a higher-than-average risk of breast and ovarian cancer. Two preventive strategies may reduce the risk of death among women with these mutations. Read more…
-
DCIS Diagnosed Outside Regular Screening Increases Invasive Disease Risk by 400%
DCIS Diagnosed Outside Regular Screening Increases Invasive Disease Risk by 400% Mar 7, 2024 If DCIS is found before regular mammograms start or in between regular screening, it more than quadruples the risk of invasive breast cancer. Read more…
-
Experimental Inavolisib Seems Promising for Certain Metastatic Breast Cancers
Experimental Inavolisib Seems Promising for Certain Metastatic Breast Cancers Dec 7, 2023 If approved, the medicine may be an alternative to Piqray for treating certain cancers with a PIK3CA mutation. Read more…
-
Soy Compounds May Reduce Breast Cancer Recurrence Risk
Soy Compounds May Reduce Breast Cancer Recurrence Risk Feb 1, 2024 Natural compounds found in soy might reduce the risk of breast cancer recurrence. Read more…
-
Long-Term Benefits of Verzenio for Early-Stage Breast Cancer Confirmed
Long-Term Benefits of Verzenio for Early-Stage Breast Cancer Confirmed Oct 30, 2023 Five years of follow-up show Verzenio continues to reduce early-stage breast cancer recurrence risk long after people stop taking it. Read more…
-
Breast Self-Exam, Mammogram Best for Finding Invasive Breast Cancer After DCIS
Breast Self-Exam, Mammogram Best for Finding Invasive Breast Cancer After DCIS Jan 15, 2024 After DCIS treatment, women who develop invasive breast cancer have the cancer found most often via mammogram or find it themselves, rather than during a doctor’s exam. Read more…
-
Exercise Lowers Breast Cancer Risk in Younger Women
Exercise Lowers Breast Cancer Risk in Younger Women Jan 12, 2024 Does just thinking about exercise make you tired? Consider this: Younger women who are more active have a lower risk of developing breast cancer. Read more…
-
Lymph Node Removal, Excess Weight Linked to Long-Term Arm Problems After Breast Cancer Treatment
Lymph Node Removal, Excess Weight Linked to Long-Term Arm Problems After Breast Cancer Treatment Jan 11, 2024 Having underarm lymph nodes removed and having obesity seem to be the top two risk factors for arm issues that can last for years after breast cancer treatment is completed. Read more…
-
Low Vitamin D Levels Up Risk of Chemotherapy-Induced Neuropathy
Low Vitamin D Levels Up Risk of Chemotherapy-Induced Neuropathy Jan 11, 2024 Low vitamin D levels increase the risk of neuropathy from chemotherapy. Read more…
-
ASTRO Updates Partial-Breast Radiation Guidelines
ASTRO Updates Partial-Breast Radiation Guidelines Jan 11, 2024 New guidelines strongly recommend partial-breast radiation after lumpectomy for many small, early-stage breast cancers with no lymph node involvement. Read more…
-
Kadcyla Continues to Improve Survival in HER2-Positive Early-Stage Breast Cancer
Kadcyla Continues to Improve Survival in HER2-Positive Early-Stage Breast Cancer Dec 17, 2023 More than eight years of follow-up from the KATHERINE trial showed the continued survival benefits of Kadcyla over Herceptin for HER2-positive breast cancer with a high risk of recurrence. Read more…
-
Breastcancer.org Research Conferences Coverage
Breastcancer.org is dedicated to bringing you the latest in breast cancer research by sending our reporters to get boots-on-the-ground breaking information at annual breast cancer conferences whenever possible. Here, we'll share our coverage and this thread will be updated as necessary in real time — make sure to bookmark…
-
Pregnancy Safe After Breast Cancer in Young Women With BRCA Mutation
Pregnancy Safe After Breast Cancer in Young Women With BRCA Mutation Dec 13, 2023 Having a child is safe for both mother and baby if women with a BRCA mutation get pregnant after a breast cancer diagnosis. Read more…
-
What Improves Sexual Well-Being After Breast Cancer? Many Women Say Self-Help
What Improves Sexual Well-Being After Breast Cancer? Many Women Say Self-Help Dec 11, 2023 When it comes to sexual functioning, many women with a history of breast cancer help themselves. Read more…
-
False-Positive Mammogram Result May Signal Higher Breast Cancer Risk
False-Positive Mammogram Result May Signal Higher Breast Cancer Risk Dec 11, 2023 Women with a false-positive mammogram result had a 61% higher risk of breast cancer in the next 20 years. Read more…
-
Chemotherapy Before Surgery May Mean Lymph Node Radiation Not Needed
Chemotherapy Before Surgery May Mean Lymph Node Radiation Not Needed Dec 5, 2023 If chemotherapy before surgery destroys cancer in the lymph nodes, radiation to the nodal area may not be needed. Read more…
-
Can Certain Younger Post-Menopausal Women With Low-Risk Breast Cancer Skip Radiation?
Can Certain Younger Post-Menopausal Women With Low-Risk Breast Cancer Skip Radiation? Dec 6, 2023 Research suggests that some younger post-menopausal women may be able to skip radiation after lumpectomy, but there are important points to consider. Read more…
-
Tukysa Plus Kadcyla Better Than Kadcyla Alone for Metastatic Breast Cancer
Tukysa Plus Kadcyla Better Than Kadcyla Alone for Metastatic Breast Cancer Dec 7, 2023 Adding Tukysa to Kadcyla improved outcomes for metastatic HER2-positive disease. Read more…
-
Obesity Ups Recurrence Risk in Women Treated With Aromatase Inhibitors
Obesity Ups Recurrence Risk in Women Treated With Aromatase Inhibitors Nov 24, 2023 The risk of breast cancer recurrence is higher in women with obesity treated with an aromatase inhibitor. Read more…
-
Vaginal Estrogen Safe for Women With Breast Cancer
Vaginal Estrogen Safe for Women With Breast Cancer Nov 21, 2023 Women with breast cancer can safely use vaginal estrogen to treat certain menopausal symptoms. Read more…
-
Lymph Node Surgery Not Needed for Certain Small Breast Cancers
Lymph Node Surgery Not Needed for Certain Small Breast Cancers Nov 21, 2023 If you’re diagnosed with a small breast cancer, you can likely skip lymph node surgery. Read more…
-
Long-Term Results Confirm Benefits of Ovarian Suppression With Tamoxifen
Long-Term Results Confirm Benefits of Ovarian Suppression With Tamoxifen Nov 21, 2023 Ovarian suppression plus tamoxifen lowers recurrence risk. Read more…
-
FDA Approves Truqap for Certain Metastatic, Hormone Receptor-Positive Breast Cancers
FDA Approves Truqap for Certain Metastatic, Hormone Receptor-Positive Breast Cancers Nov 17, 2023 Truqap is a new targeted therapy option for metastatic, hormone receptor-positive breast cancer with specific genetic mutations that has stopped responding to other hormonal therapy medicines. Read more… q
-
Dato-DXd Seems Promising As New Treatment for Certain Metastatic Breast Cancers
Dato-DXd Seems Promising As New Treatment for Certain Metastatic Breast Cancers Nov 1, 2023 The experimental medicine Dato-DXd may be a new treatment option for certain metastatic, hormone receptor-positive breast cancers. Read more…
-
Short-Term Fasting Improves Quality of Life During Chemotherapy
Short-Term Fasting Improves Quality of Life During Chemotherapy Oct 30, 2023 “The short-term fasting group didn’t even develop any clinically visible fatigue,” according to the study presenter. Read more…